B

Biosplice Therapeutics

63 employees

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2008

Funding rounds raised

Total raised

$438M

from 10 investors over 10 rounds

B

Biosplice Therapeutics raised $120M on April 15, 2021

Investors: Eventide Asset Management, aMoon Fund and Sands Capital Management

B

Biosplice Therapeutics raised $438M on August 6, 2018

Investors: Swicorp, Vickers Venture Partners and Starling International Management Limited

B

Biosplice Therapeutics raised $220M on September 1, 2013

Investors: Polar Light Ventures, Vickers Venture Partners and Starling International Management Limited

B

Biosplice Therapeutics raised undisclosed on September 1, 2012

Investors: Esas Ventures

FAQ